//img.uscri.be/pth/5d8f9c618f54fc66bd3b125cfc9a9cc9e113b5cb
Cet ouvrage fait partie de la bibliothèque YouScribe
Obtenez un accès à la bibliothèque pour le lire en ligne
En savoir plus

MFSD2A is a novel lung tumor suppressor gene modulating cell cycle and matrix attachment

De
8 pages
MFSD2A (major facilitator superfamily domain containing 2) gene maps on chromosome 1p34 within a linkage disequilibrium block containing genetic elements associated with progression of lung cancer. Results Here we show that MFSD2A expression is strongly downregulated in non-small cell lung cancer cell lines of different histotypes and in primary lung adenocarcinomas. Experimental modulation of MFSD2A in lung cancer cells is associated with alteration of mRNA levels of genes involved in cell cycle control and interaction with the extracellular matrix. Exogenous expression of MFSD2A in lung cancer cells induced a G1 block, impaired adhesion and migration in vitro , and significantly reduced tumor colony number in vitro (4- to 27-fold, P < 0.0001) and tumor volume in vivo (~3-fold, P < 0.0001). siRNA knockdown studies in normal human bronchial epithelial cells confirmed the role of MFSD2A in G1 regulation. Conclusion Together these data suggest that MFSD2A is a novel lung cancer tumor suppressor gene that regulates cell cycle progression and matrix attachment.
Voir plus Voir moins
Spinolaet al.Molecular Cancer2010,9:62 http://www.molecularcancer.com/content/9/1/62
R E S E A R C HOpen Access MFSD2A is a novel lung tumor suppressor gene modulating cell cycle and matrix attachment 1,2,3 11 2,32,3 2,3 Monica Spinola, Felicia S Falvella , Francesca Colombo , James P Sullivan, David S Shames, Luc Girard, 4 2,31* Paola Spessotto , John D Minna, Tommaso A Dragani
Abstract Background:MFSD2A (major facilitator superfamily domain containing 2) gene maps on chromosome 1p34 within a linkage disequilibrium block containing genetic elements associated with progression of lung cancer. Results:Here we show that MFSD2A expression is strongly downregulated in nonsmall cell lung cancer cell lines of different histotypes and in primary lung adenocarcinomas. Experimental modulation of MFSD2A in lung cancer cells is associated with alteration of mRNA levels of genes involved in cell cycle control and interaction with the extracellular matrix. Exogenous expression of MFSD2A in lung cancer cells induced a G1 block, impaired adhesion and migrationin vitro, and significantly reduced tumor colony numberin vitro(4 to 27fold, P < 0.0001) and tumor volumein vivo(~3fold, P < 0.0001). siRNA knockdown studies in normal human bronchial epithelial cells confirmed the role of MFSD2A in G1 regulation. Conclusion:Together these data suggest that MFSD2A is a novel lung cancer tumor suppressor gene that regulates cell cycle progression and matrix attachment.
Background Cancer progression is defined as the stepwise process through which cells evolve towards a more malignant and aggressive phenotype [1]. This process results from the accumulation of somatic genetic and epigenetic changes occurring within neoplastic cells [2]. However, a growing body of evidence also points to the role of genetic background in cancer susceptibility, progression, and prognosis [35]. We previously identified a 106 kb linkage disequilibrium block containing genetic elements associated with survival in lung adenocarcinoma (ADCA) patients [6]. The refined region maps to chro mosome 1p34 and includes MYCL1, TRIT1 (tRNA iso pentenyltransferase 1), and MFSD2A (major facilitator superfamily domain containing 2). While the role of MYCL1 and TRIT1 in lung tumor growth and develop ment has been studied [6,7], no information is available on MFSD2A. Thus, we addressed the functional role of MFSD2A in lung tumorigenesis.
* Correspondence: Tommaso.dragani@istitutotumori.mi.it 1 Department of Predictive and for Prevention Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Results Downregulation of MFSD2A in lung cancer Based on our previous finding of MFSD2A downregula tion in a pool of lung tumor specimens [7], we extended the analysis to 18 individual samples of lung ADCA tumors and corresponding benign adjacent tissue. MFSD2A mRNA levels were strongly downregulated (2 to 80fold) in 17/18 tumors with an overall 5fold decrease in ADCA as compared to normal lung speci mens (P= 5.1e05) (Fig. 1A). Statistical analysis showed no association with sex, age at diagnosis, or clinical stage (data not shown). It was not possible to evaluate association with smoking status since 17/18 patients were smokers. Measurement of MFSD2A mRNA levels in NSCLC cell lines and normal human bronchial epithelial cell (HBEC) lines (Additional file 1), normalizing the data to the average expression of HBECs, revealed downregula tion of MFSD2A (2 to 44fold) in 33/47 (70%) NSCLC cell lines but only in 4/20 (20%) HBEC lines (Fig. 1B). To identify the lung cell types expressing MFSD2A protein, we have assayed by immunohistochemistry spe cimens of normal lung tissue and lung ADCA. Using nontransfected cells as a negative control (Fig. 2A), we
© 2010 Spinola et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.